The Vanguard Group 13D and 13G filings for Atea Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-02-13 4:58 pm Sale |
2023-12-29 | 13G | Atea Pharmaceuticals, Inc. AVIR |
The Vanguard Group | 4,599,710 5.510% |
-1,489,812 (-24.47%) |
Filing |
| 2023-02-09 11:07 am Purchase |
2022-12-30 | 13G | Atea Pharmaceuticals, Inc. AVIR |
The Vanguard Group | 6,089,522 7.310% |
307,640 (+5.32%) |
Filing |
| 2022-02-09 3:24 pm Purchase |
2021-12-31 | 13G | Atea Pharmaceuticals, Inc. AVIR |
The Vanguard Group | 5,781,882 6.960% |
5,781,882 (New Position) |
Filing |